Updates are available Correction dated 2025-10-30
Click to view Correction: https://doi.org/10.1038/s41388-025-03616-5
-
Authors
Twito, Gal https://orcid.org/0009-0003-8234-317X
Abu Abayed, Faiza Amterat
Gilad, Ayelet
Biadsy, Suma
Gavriel, Noa
Sheikh Suliman, Suad
Mizrahi, Yarden
Megged, Hila
Tenenboim, Mor
Abu-Freha, Naim
Igbaria, Aeid https://orcid.org/0000-0003-3940-1824
-
Funding
Funding for this research was provided by:
Israel Science Foundation (977/21)
Ariane De Rothschild Women's Scholarship
Neubauer Doctoral Fellowships
- License Information
-
More Information
Article History
Received: 12 April 2025
Revised: 17 September 2025
Accepted: 9 October 2025
First Online: 21 October 2025
Change Date: 31 October 2025
Change Type: Update
Change Details: The original online version of this article was revised: In this article the title was incorrectly given as ‘On-genetic inactivation of caspase-3 and P53 increases cancer cell fitness by PDIA4 redistribution’ but should have been ‘Non-genetic inactivation of caspase-3 and P53 increases cancer cell fitness by PDIA4 redistribution’.
Change Date: 30 October 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41388-025-03616-5
Competing interests
: The authors declare no competing interests.
: All methods were carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all patients, and the study was approved by the ethics committee at Soroka University Medical Center (0367-23-SOR). Human samples used in this study were collected under Helsinki approval for biobank sample collection (approval number 0137-18). Approval date 12/11/2023.
